DUBLIN–(BUSINESS WIRE)–Research and Markets (http://www.researchandmarkets.com/research/t2fxnx/posterior_uveitis) has announced the addition of the “Posterior Uveitis – Pipeline Review, H1 2015” report to their offering. This report provides comprehe…
Renaissance Adds to Nationally Recognized Dental and Vision Plans in South Carolina With New Hire
INDIANAPOLIS–(BUSINESS WIRE)–Renaissance is adding nationally recognized dental and vision plans in South Carolina with new hire, Dan Pruitt.
Online map will help prepare health officials for natural disasters
The HHS has launched an interactive Geographic Information System tool, the HHS emPOWER Map, that will help community officials plan for the emergency needs of individuals that depend on electrically powered medical equipment in their homes during disaster scenarios, according to a press release. “For people who rely on electricity-dependent medical equipment, prolonged power outages can mean life or death. This tool helps communities better anticipate, plan for, and respond to these unique needs of this population and improve resilience for the entire community before and after disasters,” Nicole Lurie, (Read more...)
Researchers identify gene mutation that can cause key-hole shape defect in eye
A scientific collaboration, involving the Manchester Centre for Genomic Medicine (MCGM) at Saint Mary’s Hospital, UK, and the Telethon Institute of Genetics and Medicine (TIGEM) in Naples, Italy…
Ocata Therapeutics Announces Positive Results Reported in a Late Breaking Abstract at the Annual Meeting of the International Society for Stem Cell Research
MARLBOROUGH, Mass.–(BUSINESS WIRE)–Ocata Therapeutics, Inc. (“Ocata” or “the Company”; NASDAQ: OCAT), a leader in the field of Regenerative Ophthalmology™, announced today that data will be presented in a Late Breaking Abstract at the International Society for Stem Cell Research (ISSCR) 13th Annual Meeting being held in Stockholm, Sweden, June 24-27. The presentation will provide a follow-up of four prospective safety trials carried out in the United States and also in South Korea. The result
Bionic eye clinical trial results show long-term safety, efficacy vision-restoring implant
The three-year clinical trial results of the retinal implant popularly known as the “bionic eye,” have proven the long-term efficacy, safety and reliability of the device that restores vision in…